Gene · 170482
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TLR4+group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases. | Nat Commun | 2025 | 40753172 | PubTator, text mining | PubMed |
| Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment. | Cureus | 2025 | 40747182 | PubTator, text mining | PubMed |
| Myeloid cells as IFNα producers in systemic lupus erythematosus. | Front Immunol | 2025 | 40746538 | PubTator, text mining | PubMed |
| Spectral cytometry of rheumatoid arthritis patients implicates myeloid dendritic cells and granular HLA-DR+CD15+CD16+ cells in pro-inflammatory antigen presentation. | Front Immunol | 2025 | 40703515 | PubTator, text mining | PubMed |
| Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene. | Cancer Cell Int | 2025 | 40691845 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of Plasmacytoid Dendritic Cell Markers in Cutaneous Lupus Erythematosus Subtypes in Skin of Color. | Am J Dermatopathol | 2025 | 40553558 | PubTator, text mining | PubMed |
| Immune cell aberrations in Systemic Lupus Erythematosus: navigating the targeted therapies toward precision management. | Cell Mol Biol Lett | 2025 | 40524185 | PubTator, text mining | PubMed |
| Nodal Mature Plasmacytoid Dendritic Cell Proliferation in a Patient With Chronic Myelomonocytic Leukemia: A Diagnostic Mimic of Blastic Plasmacytoid Dendritic Cell Neoplasm. | J Investig Med High Impact Case Rep | 2025 | 40415500 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
| Identifying Immune Response Protein Biomarkers in Parkinson's-Related Cognitive Impairment and Depression. | Mol Neurobiol | 2025 | 40332667 | PubTator, text mining | PubMed |
| Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm. | Int J Mol Sci | 2025 | 40141368 | PubTator, text mining | PubMed |
| Plasmacytoid Dendritic Cell Content Is Associated With Plasma Aldosterone Concentration in Patients With Primary Aldosteronism. | Am J Hypertens | 2025 | 40056432 | PubTator, text mining | PubMed |
| A focused report on IFN-1 targeted therapies for lupus erythematosus. | Expert Opin Investig Drugs | 2025 | 40047795 | PubTator, text mining | PubMed |
| BTK-Inhibition Enhances TLR-7-Mediated Interferon-Alpha Production in pDCs by Blocking the Inhibitory BDCA-2 Pathway. | Eur J Immunol | 2025 | 39989290 | PubTator, text mining | PubMed |
| Serum Immune-Response Protein Biomarkers Based on Olink Technology for Diagnosis of Ischemic Stroke. | J Proteome Res | 2025 | 39900546 | PubTator, text mining | PubMed |
| The Challenge of Diagnosing Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report. | Anticancer Res | 2025 | 39740819 | PubTator, text mining | PubMed |
| Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape. | Clin Exp Dermatol | 2025 | 39243383 | PubTator, text mining | PubMed |
| Profiling dendritic cells subsets in renal tissue of patients with crescentic glomerulonephritis. | Int Urol Nephrol | 2025 | 39069601 | PubTator, text mining | PubMed |
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy. | Actas Dermosifiliogr | 2025 | 38852841 | PubTator, text mining | PubMed |
| Novel Prognostic Markers for Skin Cutaneous Melanoma. | Clin Cosmet Investig Dermatol | 2024 | 39588228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/170482/papers?page=3